EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Sex-specific effects of methylprednisolone on outcomes after endovascular treatment for acute ischemic stroke due to large vessel occlusion: A secondary analysis of the MARVEL trial

Lijiao Zhang, Jie Pan, Lilan Wang, Chunye Chen, Mingrui Zhou iD, Sheng Zhou, Haoxuan Zhu, Xiaolei Shi, Shihai Yang iD, Mingyang Chen, Yihui Yang, Yuhan Fan und 7 weitere

Therapeutic Advances in Neurological Disorders · 2026-08 · 19

DOI: 10.1177/17562864261473898 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Advances in Neurological Disorders, online erschienen am 31.07.2026. Verfasst von Lijiao Zhang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing,…. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China Young Scientists Fund Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sex-based differences in treatment response to neuroprotective strategies during endovascular treatment (EVT) for acute ischemic stroke remain poorly understood.

Objectives

This study aimed to evaluate sex-specific effects of methylprednisolone on outcomes after EVT for acute ischemic stroke due to large vessel occlusion.

Design

Secondary analysis of the MARVEL (Methylprednisolone as Adjunct to Endovascular Thrombectomy for Large-Vessel Occlusion Stroke) randomized controlled trial.

Methods

We compared outcomes following methylprednisolone versus placebo, stratified by sex. We also compared outcomes between women and men receiving methylprednisolone. The primary outcome was defined as the 90-day modified Rankin Scale score (mRS) ordinal shift. Secondary outcomes included mRS score of 0-4, 0-3, 0-2, 0-1 at 90 days. Safety outcomes included mortality within 90 days and symptomatic intracranial hemorrhage (sICH) within 48 hours.

Results

This study included 1680 patients (49.9% methylprednisolone, 56.7% men). Stratified by sex, among men, the methylprednisolone group was more likely to have a primary outcome compared with placebo [adjusted OR (aOR) 1.26 (1.00-1.59), P = 0.047] and reduce mortality ( P < 0.01) and sICH ( P = 0.031); among women, the primary outcome was similar between two treatment arms ( P = 0.66), with similar findings for the safety outcomes. Additionally, stratified by different treatment arms, no significant difference was found in the primary outcome between men and women treated with methylprednisolone ( P = 0.31) and placebo ( P = 0.68).

Conclusions

In this exploratory analysis, methylprednisolone appeared to be associated with better clinical outcomes in men compared with placebo. Nevertheless, the interaction between treatment and sex was not statistically significant. Furthermore, among patients receiving methylprednisolone, clinical outcomes did not differ significantly between men and women. Registration ChiCTR.org.cn Identifier: ChiCTR2100051729.

Schlagwörter

Stichwörter der Autor:innen

acute ischemic strokeendovascular treatmentlarge vessel occlusionmethylprednisoloneoutcomessex

Autor:innen und Institutionen

  • Department of Emergency, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • Department of Neurology, The 908th Hospital of Chinese People's Liberation Army Joint Logistic Support Force, Nanchang, Jiangxi, China.
  • Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • The First Clinical Medical School, Hubei University of Chinese Medicine, Wuhan, Hubei, China.
  • Department of Neurology, Renhuai People's Hospital, Renhuai, Zunyi, China.
  • Department of Neurology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.

ORCID-Profile: Mingrui Zhou, Shihai Yang, Jiaxing Song, Gaoming Li

Förderung

  • National Natural Science Foundation of China Young Scientists Fund Project

Zitieren

APA

Zhang, L., Pan, J., Wang, L., Chen, C., Zhou, M., Zhou, S., Zhu, H., Shi, X., Yang, S., Chen, M., Yang, Y., Fan, Y., Wang, B., Liu, G., Li, L., Ding, C., Song, J., Zhang, L., & Li, G. (2026). Sex-specific effects of methylprednisolone on outcomes after endovascular treatment for acute ischemic stroke due to large vessel occlusion: A secondary analysis of the MARVEL trial. Therapeutic Advances in Neurological Disorders, 19. https://doi.org/10.1177/17562864261473898

Vancouver

Zhang L, Pan J, Wang L, Chen C, Zhou M, Zhou S, et al. Sex-specific effects of methylprednisolone on outcomes after endovascular treatment for acute ischemic stroke due to large vessel occlusion: A secondary analysis of the MARVEL trial. Therapeutic Advances in Neurological Disorders. 2026;19. doi:10.1177/17562864261473898

BibTeX
@article{Zhang2026,
  author = {Zhang, Lijiao and Pan, Jie and Wang, Lilan and Chen, Chunye and Zhou, Mingrui and Zhou, Sheng and Zhu, Haoxuan and Shi, Xiaolei and Yang, Shihai and Chen, Mingyang and Yang, Yihui and Fan, Yuhan and Wang, Binghan and Liu, Guojian and Li, Linyu and Ding, Chawen and Song, Jiaxing and Zhang, Lingyu and Li, Gaoming},
  title = {Sex-specific effects of methylprednisolone on outcomes after endovascular treatment for acute ischemic stroke due to large vessel occlusion: A secondary analysis of the MARVEL trial},
  journal = {Therapeutic Advances in Neurological Disorders},
  year = {2026},
  volume = {19},
  doi = {10.1177/17562864261473898}
}
Kostenlos starten →